Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Market

Minimally Invasive Glaucoma Surgery (MIGS) Devices Comprehensive Study by Target (Trabecular Meshwork, Suprachoroidal Space, Others), Surgery (Glaucoma in Conjunction with Cataract, Stand-Alone Glaucoma), Product (MIGS Stents, MIGS Shunts, Other), End User (Hospitals, Ophthalmic Clinics, Others) Players and Region - Global Market Outlook to 2030

Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by XX Submarkets | Forecast Years 2024-2030 | CAGR: 5.3%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Minimally Invasive Glaucoma Surgery (MIGS) Devices
The minimal invasive glaucoma surgery (MIGS) procedures are expected to grow in the future due to an increase in the demand for surgery devices and government support such as favorable reimbursement policies and foreign direct investment provisions. High demand for minimally invasive glaucoma surgery devices due to various benefits such as reduced surgery time, shorter recovery period, affordability, and low risk of post-surgical complications, including hypotony. The surge in the number of glaucoma care initiatives conducted by the government and several non-governmental organizations is expected to have a positive impact on the adoption of advanced devices.

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)
CAGR5.3%


The companies are exploring the market by adopting expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions across the globe to gain a competitive advantage through combined collaborations. Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global Minimally Invasive Glaucoma Surgery (MIGS) Devices market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Alcon Inc. (Switzerland), Ellex Medical Lasers Ltd. (Australia), Glaukos Corporation (United States), Allergan Plc (United States), Santen Pharmaceutical Co., Ltd. (Japan), Lumenis (United States), Ivantis, Inc. (United States), SOLX, Inc (United States), iSTAR Medical (Belgium), InnFocus Inc. (United States), Bausch & Lomb Inc. (United States) and Neomedix Corporation (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Topcon Corporation (Japan), New World Medical, Inc (United States), Carl-Zeiss AG (Germany), IOPtima (Israel) and Abbott Medical Optics, Inc. (United States).

Segmentation Overview
AMA Research has segmented the market of Global Minimally Invasive Glaucoma Surgery (MIGS) Devices market by and Region.



On the basis of geography, the market of Minimally Invasive Glaucoma Surgery (MIGS) Devices has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by , the sub-segment i.e. will boost the Minimally Invasive Glaucoma Surgery (MIGS) Devices market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Increase in Focus of Key Players in the Development of MIGS Stents and Rise in the Demand for Combined Glaucoma and Cataract Surgeries

Market Growth Drivers:
Increased Number of Minimally Invasive Surgery Performed Around the Glob and High Benefits of Minimally Invasive Surgeries

Challenges:
Dearth of skilled professionals and Lack of Awareness about Glaucoma and Its Treatment Procedures in Underdeveloped Countries

Restraints:
Reimbursement Barriers regarding MIGS Devices and Availability of alternative treatment methods

Opportunities:
Increased Research and Development Activities, Growth Opportunities in Emerging Markets and Growing Public-Private Initiatives to Support Research Activities on Minimally Invasive Surgical Instruments

Market Leaders and their expansionary development strategies
On January 19, 2023, Alcon announced the acquisition of the MINIject Minimally Invasive Glaucoma Surgery (MIGS) device from NENTX. The MINIject is a microimplant designed to reduce intraocular pressure (IOP) in patients with glaucoma. The acquisition is expected to expand Alcon's portfolio of glaucoma treatment options and strengthen its position in the growing MIGS market.
On March 15, 2021, Ivantis, Inc. launched the Hydrus MicroStent, a second-generation trabecular micro-bypass stent designed to improve aqueous outflow in mild to moderate glaucoma patients.


Key Target Audience
Manufacturers of Minimally Invasive Glaucoma Surgery (MIGS) Devices, Suppliers of Minimally Invasive Glaucoma Surgery (MIGS) Devices, Wholesalers, Distributors, and Retailers of Minimally Invasive Glaucoma Surgery (MIGS) Devices, Healthcare Industry, Governmental Bodies and Research Firms

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Target
  • Trabecular Meshwork
  • Suprachoroidal Space
  • Others

By Surgery
  • Glaucoma in Conjunction with Cataract
  • Stand-Alone Glaucoma

By Product
  • MIGS Stents
  • MIGS Shunts
  • Other

By End User
  • Hospitals
  • Ophthalmic Clinics
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increased Number of Minimally Invasive Surgery Performed Around the Glob
      • 3.2.2. High Benefits of Minimally Invasive Surgeries
    • 3.3. Market Challenges
      • 3.3.1. Dearth of skilled professionals
      • 3.3.2. Lack of Awareness about Glaucoma and Its Treatment Procedures in Underdeveloped Countries
    • 3.4. Market Trends
      • 3.4.1. Increase in Focus of Key Players in the Development of MIGS Stents
      • 3.4.2. Rise in the Demand for Combined Glaucoma and Cataract Surgeries
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Target, Surgery, Product, End User and Region (value, volume and price ) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices (Value)
      • 5.2.1. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices by: Target (Value)
        • 5.2.1.1. Trabecular Meshwork
        • 5.2.1.2. Suprachoroidal Space
        • 5.2.1.3. Others
      • 5.2.2. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices by: Surgery (Value)
        • 5.2.2.1. Glaucoma in Conjunction with Cataract
        • 5.2.2.2. Stand-Alone Glaucoma
      • 5.2.3. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices by: Product (Value)
        • 5.2.3.1. MIGS Stents
        • 5.2.3.2. MIGS Shunts
        • 5.2.3.3. Other
      • 5.2.4. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices by: End User (Value)
        • 5.2.4.1. Hospitals
        • 5.2.4.2. Ophthalmic Clinics
        • 5.2.4.3. Others
      • 5.2.5. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices (Volume)
      • 5.3.1. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices by: Target (Volume)
        • 5.3.1.1. Trabecular Meshwork
        • 5.3.1.2. Suprachoroidal Space
        • 5.3.1.3. Others
      • 5.3.2. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices by: Surgery (Volume)
        • 5.3.2.1. Glaucoma in Conjunction with Cataract
        • 5.3.2.2. Stand-Alone Glaucoma
      • 5.3.3. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices by: Product (Volume)
        • 5.3.3.1. MIGS Stents
        • 5.3.3.2. MIGS Shunts
        • 5.3.3.3. Other
      • 5.3.4. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices by: End User (Volume)
        • 5.3.4.1. Hospitals
        • 5.3.4.2. Ophthalmic Clinics
        • 5.3.4.3. Others
      • 5.3.5. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Region
        • 5.3.5.1. South America
          • 5.3.5.1.1. Brazil
          • 5.3.5.1.2. Argentina
          • 5.3.5.1.3. Rest of South America
        • 5.3.5.2. Asia Pacific
          • 5.3.5.2.1. China
          • 5.3.5.2.2. Japan
          • 5.3.5.2.3. India
          • 5.3.5.2.4. South Korea
          • 5.3.5.2.5. Taiwan
          • 5.3.5.2.6. Australia
          • 5.3.5.2.7. Rest of Asia-Pacific
        • 5.3.5.3. Europe
          • 5.3.5.3.1. Germany
          • 5.3.5.3.2. France
          • 5.3.5.3.3. Italy
          • 5.3.5.3.4. United Kingdom
          • 5.3.5.3.5. Netherlands
          • 5.3.5.3.6. Rest of Europe
        • 5.3.5.4. MEA
          • 5.3.5.4.1. Middle East
          • 5.3.5.4.2. Africa
        • 5.3.5.5. North America
          • 5.3.5.5.1. United States
          • 5.3.5.5.2. Canada
          • 5.3.5.5.3. Mexico
    • 5.4. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices (Price)
  • 6. Minimally Invasive Glaucoma Surgery (MIGS) Devices: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Alcon Inc. (Switzerland)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Ellex Medical Lasers Ltd. (Australia)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Glaukos Corporation (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Allergan Plc (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Santen Pharmaceutical Co., Ltd. (Japan)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Lumenis (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Ivantis, Inc. (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. SOLX, Inc (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. ISTAR Medical (Belgium)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. InnFocus Inc. (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Bausch & Lomb Inc. (United States)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
      • 6.4.12. Neomedix Corporation (United States)
        • 6.4.12.1. Business Overview
        • 6.4.12.2. Products/Services Offerings
        • 6.4.12.3. Financial Analysis
        • 6.4.12.4. SWOT Analysis
  • 7. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Sale, by Target, Surgery, Product, End User and Region (value, volume and price ) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices (Value)
      • 7.2.1. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices by: Target (Value)
        • 7.2.1.1. Trabecular Meshwork
        • 7.2.1.2. Suprachoroidal Space
        • 7.2.1.3. Others
      • 7.2.2. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices by: Surgery (Value)
        • 7.2.2.1. Glaucoma in Conjunction with Cataract
        • 7.2.2.2. Stand-Alone Glaucoma
      • 7.2.3. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices by: Product (Value)
        • 7.2.3.1. MIGS Stents
        • 7.2.3.2. MIGS Shunts
        • 7.2.3.3. Other
      • 7.2.4. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices by: End User (Value)
        • 7.2.4.1. Hospitals
        • 7.2.4.2. Ophthalmic Clinics
        • 7.2.4.3. Others
      • 7.2.5. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices (Volume)
      • 7.3.1. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices by: Target (Volume)
        • 7.3.1.1. Trabecular Meshwork
        • 7.3.1.2. Suprachoroidal Space
        • 7.3.1.3. Others
      • 7.3.2. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices by: Surgery (Volume)
        • 7.3.2.1. Glaucoma in Conjunction with Cataract
        • 7.3.2.2. Stand-Alone Glaucoma
      • 7.3.3. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices by: Product (Volume)
        • 7.3.3.1. MIGS Stents
        • 7.3.3.2. MIGS Shunts
        • 7.3.3.3. Other
      • 7.3.4. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices by: End User (Volume)
        • 7.3.4.1. Hospitals
        • 7.3.4.2. Ophthalmic Clinics
        • 7.3.4.3. Others
      • 7.3.5. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Region
        • 7.3.5.1. South America
          • 7.3.5.1.1. Brazil
          • 7.3.5.1.2. Argentina
          • 7.3.5.1.3. Rest of South America
        • 7.3.5.2. Asia Pacific
          • 7.3.5.2.1. China
          • 7.3.5.2.2. Japan
          • 7.3.5.2.3. India
          • 7.3.5.2.4. South Korea
          • 7.3.5.2.5. Taiwan
          • 7.3.5.2.6. Australia
          • 7.3.5.2.7. Rest of Asia-Pacific
        • 7.3.5.3. Europe
          • 7.3.5.3.1. Germany
          • 7.3.5.3.2. France
          • 7.3.5.3.3. Italy
          • 7.3.5.3.4. United Kingdom
          • 7.3.5.3.5. Netherlands
          • 7.3.5.3.6. Rest of Europe
        • 7.3.5.4. MEA
          • 7.3.5.4.1. Middle East
          • 7.3.5.4.2. Africa
        • 7.3.5.5. North America
          • 7.3.5.5.1. United States
          • 7.3.5.5.2. Canada
          • 7.3.5.5.3. Mexico
    • 7.4. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Minimally Invasive Glaucoma Surgery (MIGS) Devices: by Target(USD Million)
  • Table 2. Minimally Invasive Glaucoma Surgery (MIGS) Devices Trabecular Meshwork , by Region USD Million (2018-2023)
  • Table 3. Minimally Invasive Glaucoma Surgery (MIGS) Devices Suprachoroidal Space , by Region USD Million (2018-2023)
  • Table 4. Minimally Invasive Glaucoma Surgery (MIGS) Devices Others , by Region USD Million (2018-2023)
  • Table 5. Minimally Invasive Glaucoma Surgery (MIGS) Devices: by Surgery(USD Million)
  • Table 6. Minimally Invasive Glaucoma Surgery (MIGS) Devices Glaucoma in Conjunction with Cataract , by Region USD Million (2018-2023)
  • Table 7. Minimally Invasive Glaucoma Surgery (MIGS) Devices Stand-Alone Glaucoma , by Region USD Million (2018-2023)
  • Table 8. Minimally Invasive Glaucoma Surgery (MIGS) Devices: by Product(USD Million)
  • Table 9. Minimally Invasive Glaucoma Surgery (MIGS) Devices MIGS Stents , by Region USD Million (2018-2023)
  • Table 10. Minimally Invasive Glaucoma Surgery (MIGS) Devices MIGS Shunts , by Region USD Million (2018-2023)
  • Table 11. Minimally Invasive Glaucoma Surgery (MIGS) Devices Other , by Region USD Million (2018-2023)
  • Table 12. Minimally Invasive Glaucoma Surgery (MIGS) Devices: by End User(USD Million)
  • Table 13. Minimally Invasive Glaucoma Surgery (MIGS) Devices Hospitals , by Region USD Million (2018-2023)
  • Table 14. Minimally Invasive Glaucoma Surgery (MIGS) Devices Ophthalmic Clinics , by Region USD Million (2018-2023)
  • Table 15. Minimally Invasive Glaucoma Surgery (MIGS) Devices Others , by Region USD Million (2018-2023)
  • Table 16. South America Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Country USD Million (2018-2023)
  • Table 17. South America Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Target USD Million (2018-2023)
  • Table 18. South America Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Surgery USD Million (2018-2023)
  • Table 19. South America Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Product USD Million (2018-2023)
  • Table 20. South America Minimally Invasive Glaucoma Surgery (MIGS) Devices, by End User USD Million (2018-2023)
  • Table 21. Brazil Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Target USD Million (2018-2023)
  • Table 22. Brazil Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Surgery USD Million (2018-2023)
  • Table 23. Brazil Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Product USD Million (2018-2023)
  • Table 24. Brazil Minimally Invasive Glaucoma Surgery (MIGS) Devices, by End User USD Million (2018-2023)
  • Table 25. Argentina Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Target USD Million (2018-2023)
  • Table 26. Argentina Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Surgery USD Million (2018-2023)
  • Table 27. Argentina Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Product USD Million (2018-2023)
  • Table 28. Argentina Minimally Invasive Glaucoma Surgery (MIGS) Devices, by End User USD Million (2018-2023)
  • Table 29. Rest of South America Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Target USD Million (2018-2023)
  • Table 30. Rest of South America Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Surgery USD Million (2018-2023)
  • Table 31. Rest of South America Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Product USD Million (2018-2023)
  • Table 32. Rest of South America Minimally Invasive Glaucoma Surgery (MIGS) Devices, by End User USD Million (2018-2023)
  • Table 33. Asia Pacific Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Country USD Million (2018-2023)
  • Table 34. Asia Pacific Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Target USD Million (2018-2023)
  • Table 35. Asia Pacific Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Surgery USD Million (2018-2023)
  • Table 36. Asia Pacific Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Product USD Million (2018-2023)
  • Table 37. Asia Pacific Minimally Invasive Glaucoma Surgery (MIGS) Devices, by End User USD Million (2018-2023)
  • Table 38. China Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Target USD Million (2018-2023)
  • Table 39. China Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Surgery USD Million (2018-2023)
  • Table 40. China Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Product USD Million (2018-2023)
  • Table 41. China Minimally Invasive Glaucoma Surgery (MIGS) Devices, by End User USD Million (2018-2023)
  • Table 42. Japan Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Target USD Million (2018-2023)
  • Table 43. Japan Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Surgery USD Million (2018-2023)
  • Table 44. Japan Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Product USD Million (2018-2023)
  • Table 45. Japan Minimally Invasive Glaucoma Surgery (MIGS) Devices, by End User USD Million (2018-2023)
  • Table 46. India Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Target USD Million (2018-2023)
  • Table 47. India Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Surgery USD Million (2018-2023)
  • Table 48. India Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Product USD Million (2018-2023)
  • Table 49. India Minimally Invasive Glaucoma Surgery (MIGS) Devices, by End User USD Million (2018-2023)
  • Table 50. South Korea Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Target USD Million (2018-2023)
  • Table 51. South Korea Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Surgery USD Million (2018-2023)
  • Table 52. South Korea Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Product USD Million (2018-2023)
  • Table 53. South Korea Minimally Invasive Glaucoma Surgery (MIGS) Devices, by End User USD Million (2018-2023)
  • Table 54. Taiwan Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Target USD Million (2018-2023)
  • Table 55. Taiwan Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Surgery USD Million (2018-2023)
  • Table 56. Taiwan Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Product USD Million (2018-2023)
  • Table 57. Taiwan Minimally Invasive Glaucoma Surgery (MIGS) Devices, by End User USD Million (2018-2023)
  • Table 58. Australia Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Target USD Million (2018-2023)
  • Table 59. Australia Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Surgery USD Million (2018-2023)
  • Table 60. Australia Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Product USD Million (2018-2023)
  • Table 61. Australia Minimally Invasive Glaucoma Surgery (MIGS) Devices, by End User USD Million (2018-2023)
  • Table 62. Rest of Asia-Pacific Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Target USD Million (2018-2023)
  • Table 63. Rest of Asia-Pacific Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Surgery USD Million (2018-2023)
  • Table 64. Rest of Asia-Pacific Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Product USD Million (2018-2023)
  • Table 65. Rest of Asia-Pacific Minimally Invasive Glaucoma Surgery (MIGS) Devices, by End User USD Million (2018-2023)
  • Table 66. Europe Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Country USD Million (2018-2023)
  • Table 67. Europe Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Target USD Million (2018-2023)
  • Table 68. Europe Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Surgery USD Million (2018-2023)
  • Table 69. Europe Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Product USD Million (2018-2023)
  • Table 70. Europe Minimally Invasive Glaucoma Surgery (MIGS) Devices, by End User USD Million (2018-2023)
  • Table 71. Germany Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Target USD Million (2018-2023)
  • Table 72. Germany Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Surgery USD Million (2018-2023)
  • Table 73. Germany Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Product USD Million (2018-2023)
  • Table 74. Germany Minimally Invasive Glaucoma Surgery (MIGS) Devices, by End User USD Million (2018-2023)
  • Table 75. France Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Target USD Million (2018-2023)
  • Table 76. France Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Surgery USD Million (2018-2023)
  • Table 77. France Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Product USD Million (2018-2023)
  • Table 78. France Minimally Invasive Glaucoma Surgery (MIGS) Devices, by End User USD Million (2018-2023)
  • Table 79. Italy Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Target USD Million (2018-2023)
  • Table 80. Italy Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Surgery USD Million (2018-2023)
  • Table 81. Italy Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Product USD Million (2018-2023)
  • Table 82. Italy Minimally Invasive Glaucoma Surgery (MIGS) Devices, by End User USD Million (2018-2023)
  • Table 83. United Kingdom Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Target USD Million (2018-2023)
  • Table 84. United Kingdom Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Surgery USD Million (2018-2023)
  • Table 85. United Kingdom Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Product USD Million (2018-2023)
  • Table 86. United Kingdom Minimally Invasive Glaucoma Surgery (MIGS) Devices, by End User USD Million (2018-2023)
  • Table 87. Netherlands Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Target USD Million (2018-2023)
  • Table 88. Netherlands Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Surgery USD Million (2018-2023)
  • Table 89. Netherlands Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Product USD Million (2018-2023)
  • Table 90. Netherlands Minimally Invasive Glaucoma Surgery (MIGS) Devices, by End User USD Million (2018-2023)
  • Table 91. Rest of Europe Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Target USD Million (2018-2023)
  • Table 92. Rest of Europe Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Surgery USD Million (2018-2023)
  • Table 93. Rest of Europe Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Product USD Million (2018-2023)
  • Table 94. Rest of Europe Minimally Invasive Glaucoma Surgery (MIGS) Devices, by End User USD Million (2018-2023)
  • Table 95. MEA Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Country USD Million (2018-2023)
  • Table 96. MEA Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Target USD Million (2018-2023)
  • Table 97. MEA Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Surgery USD Million (2018-2023)
  • Table 98. MEA Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Product USD Million (2018-2023)
  • Table 99. MEA Minimally Invasive Glaucoma Surgery (MIGS) Devices, by End User USD Million (2018-2023)
  • Table 100. Middle East Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Target USD Million (2018-2023)
  • Table 101. Middle East Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Surgery USD Million (2018-2023)
  • Table 102. Middle East Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Product USD Million (2018-2023)
  • Table 103. Middle East Minimally Invasive Glaucoma Surgery (MIGS) Devices, by End User USD Million (2018-2023)
  • Table 104. Africa Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Target USD Million (2018-2023)
  • Table 105. Africa Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Surgery USD Million (2018-2023)
  • Table 106. Africa Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Product USD Million (2018-2023)
  • Table 107. Africa Minimally Invasive Glaucoma Surgery (MIGS) Devices, by End User USD Million (2018-2023)
  • Table 108. North America Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Country USD Million (2018-2023)
  • Table 109. North America Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Target USD Million (2018-2023)
  • Table 110. North America Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Surgery USD Million (2018-2023)
  • Table 111. North America Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Product USD Million (2018-2023)
  • Table 112. North America Minimally Invasive Glaucoma Surgery (MIGS) Devices, by End User USD Million (2018-2023)
  • Table 113. United States Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Target USD Million (2018-2023)
  • Table 114. United States Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Surgery USD Million (2018-2023)
  • Table 115. United States Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Product USD Million (2018-2023)
  • Table 116. United States Minimally Invasive Glaucoma Surgery (MIGS) Devices, by End User USD Million (2018-2023)
  • Table 117. Canada Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Target USD Million (2018-2023)
  • Table 118. Canada Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Surgery USD Million (2018-2023)
  • Table 119. Canada Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Product USD Million (2018-2023)
  • Table 120. Canada Minimally Invasive Glaucoma Surgery (MIGS) Devices, by End User USD Million (2018-2023)
  • Table 121. Mexico Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Target USD Million (2018-2023)
  • Table 122. Mexico Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Surgery USD Million (2018-2023)
  • Table 123. Mexico Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Product USD Million (2018-2023)
  • Table 124. Mexico Minimally Invasive Glaucoma Surgery (MIGS) Devices, by End User USD Million (2018-2023)
  • Table 125. Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales: by Target(K Unit)
  • Table 126. Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales Trabecular Meshwork , by Region K Unit (2018-2023)
  • Table 127. Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales Suprachoroidal Space , by Region K Unit (2018-2023)
  • Table 128. Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales Others , by Region K Unit (2018-2023)
  • Table 129. Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales: by Surgery(K Unit)
  • Table 130. Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales Glaucoma in Conjunction with Cataract , by Region K Unit (2018-2023)
  • Table 131. Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales Stand-Alone Glaucoma , by Region K Unit (2018-2023)
  • Table 132. Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales: by Product(K Unit)
  • Table 133. Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales MIGS Stents , by Region K Unit (2018-2023)
  • Table 134. Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales MIGS Shunts , by Region K Unit (2018-2023)
  • Table 135. Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales Other , by Region K Unit (2018-2023)
  • Table 136. Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales: by End User(K Unit)
  • Table 137. Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales Hospitals , by Region K Unit (2018-2023)
  • Table 138. Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales Ophthalmic Clinics , by Region K Unit (2018-2023)
  • Table 139. Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales Others , by Region K Unit (2018-2023)
  • Table 140. South America Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Country K Unit (2018-2023)
  • Table 141. South America Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Target K Unit (2018-2023)
  • Table 142. South America Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Surgery K Unit (2018-2023)
  • Table 143. South America Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Product K Unit (2018-2023)
  • Table 144. South America Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by End User K Unit (2018-2023)
  • Table 145. Brazil Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Target K Unit (2018-2023)
  • Table 146. Brazil Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Surgery K Unit (2018-2023)
  • Table 147. Brazil Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Product K Unit (2018-2023)
  • Table 148. Brazil Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by End User K Unit (2018-2023)
  • Table 149. Argentina Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Target K Unit (2018-2023)
  • Table 150. Argentina Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Surgery K Unit (2018-2023)
  • Table 151. Argentina Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Product K Unit (2018-2023)
  • Table 152. Argentina Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by End User K Unit (2018-2023)
  • Table 153. Rest of South America Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Target K Unit (2018-2023)
  • Table 154. Rest of South America Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Surgery K Unit (2018-2023)
  • Table 155. Rest of South America Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Product K Unit (2018-2023)
  • Table 156. Rest of South America Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by End User K Unit (2018-2023)
  • Table 157. Asia Pacific Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Country K Unit (2018-2023)
  • Table 158. Asia Pacific Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Target K Unit (2018-2023)
  • Table 159. Asia Pacific Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Surgery K Unit (2018-2023)
  • Table 160. Asia Pacific Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Product K Unit (2018-2023)
  • Table 161. Asia Pacific Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by End User K Unit (2018-2023)
  • Table 162. China Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Target K Unit (2018-2023)
  • Table 163. China Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Surgery K Unit (2018-2023)
  • Table 164. China Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Product K Unit (2018-2023)
  • Table 165. China Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by End User K Unit (2018-2023)
  • Table 166. Japan Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Target K Unit (2018-2023)
  • Table 167. Japan Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Surgery K Unit (2018-2023)
  • Table 168. Japan Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Product K Unit (2018-2023)
  • Table 169. Japan Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by End User K Unit (2018-2023)
  • Table 170. India Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Target K Unit (2018-2023)
  • Table 171. India Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Surgery K Unit (2018-2023)
  • Table 172. India Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Product K Unit (2018-2023)
  • Table 173. India Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by End User K Unit (2018-2023)
  • Table 174. South Korea Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Target K Unit (2018-2023)
  • Table 175. South Korea Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Surgery K Unit (2018-2023)
  • Table 176. South Korea Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Product K Unit (2018-2023)
  • Table 177. South Korea Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by End User K Unit (2018-2023)
  • Table 178. Taiwan Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Target K Unit (2018-2023)
  • Table 179. Taiwan Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Surgery K Unit (2018-2023)
  • Table 180. Taiwan Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Product K Unit (2018-2023)
  • Table 181. Taiwan Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by End User K Unit (2018-2023)
  • Table 182. Australia Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Target K Unit (2018-2023)
  • Table 183. Australia Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Surgery K Unit (2018-2023)
  • Table 184. Australia Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Product K Unit (2018-2023)
  • Table 185. Australia Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by End User K Unit (2018-2023)
  • Table 186. Rest of Asia-Pacific Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Target K Unit (2018-2023)
  • Table 187. Rest of Asia-Pacific Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Surgery K Unit (2018-2023)
  • Table 188. Rest of Asia-Pacific Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Product K Unit (2018-2023)
  • Table 189. Rest of Asia-Pacific Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by End User K Unit (2018-2023)
  • Table 190. Europe Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Country K Unit (2018-2023)
  • Table 191. Europe Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Target K Unit (2018-2023)
  • Table 192. Europe Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Surgery K Unit (2018-2023)
  • Table 193. Europe Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Product K Unit (2018-2023)
  • Table 194. Europe Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by End User K Unit (2018-2023)
  • Table 195. Germany Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Target K Unit (2018-2023)
  • Table 196. Germany Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Surgery K Unit (2018-2023)
  • Table 197. Germany Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Product K Unit (2018-2023)
  • Table 198. Germany Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by End User K Unit (2018-2023)
  • Table 199. France Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Target K Unit (2018-2023)
  • Table 200. France Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Surgery K Unit (2018-2023)
  • Table 201. France Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Product K Unit (2018-2023)
  • Table 202. France Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by End User K Unit (2018-2023)
  • Table 203. Italy Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Target K Unit (2018-2023)
  • Table 204. Italy Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Surgery K Unit (2018-2023)
  • Table 205. Italy Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Product K Unit (2018-2023)
  • Table 206. Italy Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by End User K Unit (2018-2023)
  • Table 207. United Kingdom Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Target K Unit (2018-2023)
  • Table 208. United Kingdom Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Surgery K Unit (2018-2023)
  • Table 209. United Kingdom Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Product K Unit (2018-2023)
  • Table 210. United Kingdom Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by End User K Unit (2018-2023)
  • Table 211. Netherlands Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Target K Unit (2018-2023)
  • Table 212. Netherlands Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Surgery K Unit (2018-2023)
  • Table 213. Netherlands Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Product K Unit (2018-2023)
  • Table 214. Netherlands Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by End User K Unit (2018-2023)
  • Table 215. Rest of Europe Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Target K Unit (2018-2023)
  • Table 216. Rest of Europe Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Surgery K Unit (2018-2023)
  • Table 217. Rest of Europe Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Product K Unit (2018-2023)
  • Table 218. Rest of Europe Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by End User K Unit (2018-2023)
  • Table 219. MEA Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Country K Unit (2018-2023)
  • Table 220. MEA Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Target K Unit (2018-2023)
  • Table 221. MEA Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Surgery K Unit (2018-2023)
  • Table 222. MEA Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Product K Unit (2018-2023)
  • Table 223. MEA Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by End User K Unit (2018-2023)
  • Table 224. Middle East Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Target K Unit (2018-2023)
  • Table 225. Middle East Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Surgery K Unit (2018-2023)
  • Table 226. Middle East Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Product K Unit (2018-2023)
  • Table 227. Middle East Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by End User K Unit (2018-2023)
  • Table 228. Africa Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Target K Unit (2018-2023)
  • Table 229. Africa Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Surgery K Unit (2018-2023)
  • Table 230. Africa Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Product K Unit (2018-2023)
  • Table 231. Africa Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by End User K Unit (2018-2023)
  • Table 232. North America Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Country K Unit (2018-2023)
  • Table 233. North America Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Target K Unit (2018-2023)
  • Table 234. North America Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Surgery K Unit (2018-2023)
  • Table 235. North America Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Product K Unit (2018-2023)
  • Table 236. North America Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by End User K Unit (2018-2023)
  • Table 237. United States Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Target K Unit (2018-2023)
  • Table 238. United States Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Surgery K Unit (2018-2023)
  • Table 239. United States Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Product K Unit (2018-2023)
  • Table 240. United States Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by End User K Unit (2018-2023)
  • Table 241. Canada Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Target K Unit (2018-2023)
  • Table 242. Canada Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Surgery K Unit (2018-2023)
  • Table 243. Canada Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Product K Unit (2018-2023)
  • Table 244. Canada Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by End User K Unit (2018-2023)
  • Table 245. Mexico Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Target K Unit (2018-2023)
  • Table 246. Mexico Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Surgery K Unit (2018-2023)
  • Table 247. Mexico Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Product K Unit (2018-2023)
  • Table 248. Mexico Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by End User K Unit (2018-2023)
  • Table 249. Company Basic Information, Sales Area and Its Competitors
  • Table 250. Company Basic Information, Sales Area and Its Competitors
  • Table 251. Company Basic Information, Sales Area and Its Competitors
  • Table 252. Company Basic Information, Sales Area and Its Competitors
  • Table 253. Company Basic Information, Sales Area and Its Competitors
  • Table 254. Company Basic Information, Sales Area and Its Competitors
  • Table 255. Company Basic Information, Sales Area and Its Competitors
  • Table 256. Company Basic Information, Sales Area and Its Competitors
  • Table 257. Company Basic Information, Sales Area and Its Competitors
  • Table 258. Company Basic Information, Sales Area and Its Competitors
  • Table 259. Company Basic Information, Sales Area and Its Competitors
  • Table 260. Company Basic Information, Sales Area and Its Competitors
  • Table 261. Minimally Invasive Glaucoma Surgery (MIGS) Devices: by Target(USD Million)
  • Table 262. Minimally Invasive Glaucoma Surgery (MIGS) Devices Trabecular Meshwork , by Region USD Million (2025-2030)
  • Table 263. Minimally Invasive Glaucoma Surgery (MIGS) Devices Suprachoroidal Space , by Region USD Million (2025-2030)
  • Table 264. Minimally Invasive Glaucoma Surgery (MIGS) Devices Others , by Region USD Million (2025-2030)
  • Table 265. Minimally Invasive Glaucoma Surgery (MIGS) Devices: by Surgery(USD Million)
  • Table 266. Minimally Invasive Glaucoma Surgery (MIGS) Devices Glaucoma in Conjunction with Cataract , by Region USD Million (2025-2030)
  • Table 267. Minimally Invasive Glaucoma Surgery (MIGS) Devices Stand-Alone Glaucoma , by Region USD Million (2025-2030)
  • Table 268. Minimally Invasive Glaucoma Surgery (MIGS) Devices: by Product(USD Million)
  • Table 269. Minimally Invasive Glaucoma Surgery (MIGS) Devices MIGS Stents , by Region USD Million (2025-2030)
  • Table 270. Minimally Invasive Glaucoma Surgery (MIGS) Devices MIGS Shunts , by Region USD Million (2025-2030)
  • Table 271. Minimally Invasive Glaucoma Surgery (MIGS) Devices Other , by Region USD Million (2025-2030)
  • Table 272. Minimally Invasive Glaucoma Surgery (MIGS) Devices: by End User(USD Million)
  • Table 273. Minimally Invasive Glaucoma Surgery (MIGS) Devices Hospitals , by Region USD Million (2025-2030)
  • Table 274. Minimally Invasive Glaucoma Surgery (MIGS) Devices Ophthalmic Clinics , by Region USD Million (2025-2030)
  • Table 275. Minimally Invasive Glaucoma Surgery (MIGS) Devices Others , by Region USD Million (2025-2030)
  • Table 276. South America Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Country USD Million (2025-2030)
  • Table 277. South America Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Target USD Million (2025-2030)
  • Table 278. South America Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Surgery USD Million (2025-2030)
  • Table 279. South America Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Product USD Million (2025-2030)
  • Table 280. South America Minimally Invasive Glaucoma Surgery (MIGS) Devices, by End User USD Million (2025-2030)
  • Table 281. Brazil Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Target USD Million (2025-2030)
  • Table 282. Brazil Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Surgery USD Million (2025-2030)
  • Table 283. Brazil Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Product USD Million (2025-2030)
  • Table 284. Brazil Minimally Invasive Glaucoma Surgery (MIGS) Devices, by End User USD Million (2025-2030)
  • Table 285. Argentina Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Target USD Million (2025-2030)
  • Table 286. Argentina Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Surgery USD Million (2025-2030)
  • Table 287. Argentina Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Product USD Million (2025-2030)
  • Table 288. Argentina Minimally Invasive Glaucoma Surgery (MIGS) Devices, by End User USD Million (2025-2030)
  • Table 289. Rest of South America Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Target USD Million (2025-2030)
  • Table 290. Rest of South America Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Surgery USD Million (2025-2030)
  • Table 291. Rest of South America Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Product USD Million (2025-2030)
  • Table 292. Rest of South America Minimally Invasive Glaucoma Surgery (MIGS) Devices, by End User USD Million (2025-2030)
  • Table 293. Asia Pacific Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Country USD Million (2025-2030)
  • Table 294. Asia Pacific Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Target USD Million (2025-2030)
  • Table 295. Asia Pacific Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Surgery USD Million (2025-2030)
  • Table 296. Asia Pacific Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Product USD Million (2025-2030)
  • Table 297. Asia Pacific Minimally Invasive Glaucoma Surgery (MIGS) Devices, by End User USD Million (2025-2030)
  • Table 298. China Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Target USD Million (2025-2030)
  • Table 299. China Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Surgery USD Million (2025-2030)
  • Table 300. China Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Product USD Million (2025-2030)
  • Table 301. China Minimally Invasive Glaucoma Surgery (MIGS) Devices, by End User USD Million (2025-2030)
  • Table 302. Japan Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Target USD Million (2025-2030)
  • Table 303. Japan Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Surgery USD Million (2025-2030)
  • Table 304. Japan Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Product USD Million (2025-2030)
  • Table 305. Japan Minimally Invasive Glaucoma Surgery (MIGS) Devices, by End User USD Million (2025-2030)
  • Table 306. India Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Target USD Million (2025-2030)
  • Table 307. India Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Surgery USD Million (2025-2030)
  • Table 308. India Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Product USD Million (2025-2030)
  • Table 309. India Minimally Invasive Glaucoma Surgery (MIGS) Devices, by End User USD Million (2025-2030)
  • Table 310. South Korea Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Target USD Million (2025-2030)
  • Table 311. South Korea Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Surgery USD Million (2025-2030)
  • Table 312. South Korea Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Product USD Million (2025-2030)
  • Table 313. South Korea Minimally Invasive Glaucoma Surgery (MIGS) Devices, by End User USD Million (2025-2030)
  • Table 314. Taiwan Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Target USD Million (2025-2030)
  • Table 315. Taiwan Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Surgery USD Million (2025-2030)
  • Table 316. Taiwan Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Product USD Million (2025-2030)
  • Table 317. Taiwan Minimally Invasive Glaucoma Surgery (MIGS) Devices, by End User USD Million (2025-2030)
  • Table 318. Australia Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Target USD Million (2025-2030)
  • Table 319. Australia Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Surgery USD Million (2025-2030)
  • Table 320. Australia Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Product USD Million (2025-2030)
  • Table 321. Australia Minimally Invasive Glaucoma Surgery (MIGS) Devices, by End User USD Million (2025-2030)
  • Table 322. Rest of Asia-Pacific Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Target USD Million (2025-2030)
  • Table 323. Rest of Asia-Pacific Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Surgery USD Million (2025-2030)
  • Table 324. Rest of Asia-Pacific Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Product USD Million (2025-2030)
  • Table 325. Rest of Asia-Pacific Minimally Invasive Glaucoma Surgery (MIGS) Devices, by End User USD Million (2025-2030)
  • Table 326. Europe Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Country USD Million (2025-2030)
  • Table 327. Europe Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Target USD Million (2025-2030)
  • Table 328. Europe Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Surgery USD Million (2025-2030)
  • Table 329. Europe Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Product USD Million (2025-2030)
  • Table 330. Europe Minimally Invasive Glaucoma Surgery (MIGS) Devices, by End User USD Million (2025-2030)
  • Table 331. Germany Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Target USD Million (2025-2030)
  • Table 332. Germany Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Surgery USD Million (2025-2030)
  • Table 333. Germany Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Product USD Million (2025-2030)
  • Table 334. Germany Minimally Invasive Glaucoma Surgery (MIGS) Devices, by End User USD Million (2025-2030)
  • Table 335. France Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Target USD Million (2025-2030)
  • Table 336. France Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Surgery USD Million (2025-2030)
  • Table 337. France Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Product USD Million (2025-2030)
  • Table 338. France Minimally Invasive Glaucoma Surgery (MIGS) Devices, by End User USD Million (2025-2030)
  • Table 339. Italy Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Target USD Million (2025-2030)
  • Table 340. Italy Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Surgery USD Million (2025-2030)
  • Table 341. Italy Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Product USD Million (2025-2030)
  • Table 342. Italy Minimally Invasive Glaucoma Surgery (MIGS) Devices, by End User USD Million (2025-2030)
  • Table 343. United Kingdom Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Target USD Million (2025-2030)
  • Table 344. United Kingdom Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Surgery USD Million (2025-2030)
  • Table 345. United Kingdom Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Product USD Million (2025-2030)
  • Table 346. United Kingdom Minimally Invasive Glaucoma Surgery (MIGS) Devices, by End User USD Million (2025-2030)
  • Table 347. Netherlands Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Target USD Million (2025-2030)
  • Table 348. Netherlands Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Surgery USD Million (2025-2030)
  • Table 349. Netherlands Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Product USD Million (2025-2030)
  • Table 350. Netherlands Minimally Invasive Glaucoma Surgery (MIGS) Devices, by End User USD Million (2025-2030)
  • Table 351. Rest of Europe Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Target USD Million (2025-2030)
  • Table 352. Rest of Europe Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Surgery USD Million (2025-2030)
  • Table 353. Rest of Europe Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Product USD Million (2025-2030)
  • Table 354. Rest of Europe Minimally Invasive Glaucoma Surgery (MIGS) Devices, by End User USD Million (2025-2030)
  • Table 355. MEA Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Country USD Million (2025-2030)
  • Table 356. MEA Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Target USD Million (2025-2030)
  • Table 357. MEA Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Surgery USD Million (2025-2030)
  • Table 358. MEA Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Product USD Million (2025-2030)
  • Table 359. MEA Minimally Invasive Glaucoma Surgery (MIGS) Devices, by End User USD Million (2025-2030)
  • Table 360. Middle East Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Target USD Million (2025-2030)
  • Table 361. Middle East Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Surgery USD Million (2025-2030)
  • Table 362. Middle East Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Product USD Million (2025-2030)
  • Table 363. Middle East Minimally Invasive Glaucoma Surgery (MIGS) Devices, by End User USD Million (2025-2030)
  • Table 364. Africa Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Target USD Million (2025-2030)
  • Table 365. Africa Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Surgery USD Million (2025-2030)
  • Table 366. Africa Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Product USD Million (2025-2030)
  • Table 367. Africa Minimally Invasive Glaucoma Surgery (MIGS) Devices, by End User USD Million (2025-2030)
  • Table 368. North America Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Country USD Million (2025-2030)
  • Table 369. North America Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Target USD Million (2025-2030)
  • Table 370. North America Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Surgery USD Million (2025-2030)
  • Table 371. North America Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Product USD Million (2025-2030)
  • Table 372. North America Minimally Invasive Glaucoma Surgery (MIGS) Devices, by End User USD Million (2025-2030)
  • Table 373. United States Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Target USD Million (2025-2030)
  • Table 374. United States Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Surgery USD Million (2025-2030)
  • Table 375. United States Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Product USD Million (2025-2030)
  • Table 376. United States Minimally Invasive Glaucoma Surgery (MIGS) Devices, by End User USD Million (2025-2030)
  • Table 377. Canada Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Target USD Million (2025-2030)
  • Table 378. Canada Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Surgery USD Million (2025-2030)
  • Table 379. Canada Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Product USD Million (2025-2030)
  • Table 380. Canada Minimally Invasive Glaucoma Surgery (MIGS) Devices, by End User USD Million (2025-2030)
  • Table 381. Mexico Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Target USD Million (2025-2030)
  • Table 382. Mexico Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Surgery USD Million (2025-2030)
  • Table 383. Mexico Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Product USD Million (2025-2030)
  • Table 384. Mexico Minimally Invasive Glaucoma Surgery (MIGS) Devices, by End User USD Million (2025-2030)
  • Table 385. Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales: by Target(K Unit)
  • Table 386. Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales Trabecular Meshwork , by Region K Unit (2025-2030)
  • Table 387. Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales Suprachoroidal Space , by Region K Unit (2025-2030)
  • Table 388. Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales Others , by Region K Unit (2025-2030)
  • Table 389. Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales: by Surgery(K Unit)
  • Table 390. Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales Glaucoma in Conjunction with Cataract , by Region K Unit (2025-2030)
  • Table 391. Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales Stand-Alone Glaucoma , by Region K Unit (2025-2030)
  • Table 392. Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales: by Product(K Unit)
  • Table 393. Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales MIGS Stents , by Region K Unit (2025-2030)
  • Table 394. Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales MIGS Shunts , by Region K Unit (2025-2030)
  • Table 395. Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales Other , by Region K Unit (2025-2030)
  • Table 396. Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales: by End User(K Unit)
  • Table 397. Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales Hospitals , by Region K Unit (2025-2030)
  • Table 398. Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales Ophthalmic Clinics , by Region K Unit (2025-2030)
  • Table 399. Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales Others , by Region K Unit (2025-2030)
  • Table 400. South America Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Country K Unit (2025-2030)
  • Table 401. South America Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Target K Unit (2025-2030)
  • Table 402. South America Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Surgery K Unit (2025-2030)
  • Table 403. South America Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Product K Unit (2025-2030)
  • Table 404. South America Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by End User K Unit (2025-2030)
  • Table 405. Brazil Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Target K Unit (2025-2030)
  • Table 406. Brazil Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Surgery K Unit (2025-2030)
  • Table 407. Brazil Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Product K Unit (2025-2030)
  • Table 408. Brazil Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by End User K Unit (2025-2030)
  • Table 409. Argentina Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Target K Unit (2025-2030)
  • Table 410. Argentina Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Surgery K Unit (2025-2030)
  • Table 411. Argentina Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Product K Unit (2025-2030)
  • Table 412. Argentina Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by End User K Unit (2025-2030)
  • Table 413. Rest of South America Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Target K Unit (2025-2030)
  • Table 414. Rest of South America Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Surgery K Unit (2025-2030)
  • Table 415. Rest of South America Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Product K Unit (2025-2030)
  • Table 416. Rest of South America Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by End User K Unit (2025-2030)
  • Table 417. Asia Pacific Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Country K Unit (2025-2030)
  • Table 418. Asia Pacific Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Target K Unit (2025-2030)
  • Table 419. Asia Pacific Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Surgery K Unit (2025-2030)
  • Table 420. Asia Pacific Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Product K Unit (2025-2030)
  • Table 421. Asia Pacific Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by End User K Unit (2025-2030)
  • Table 422. China Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Target K Unit (2025-2030)
  • Table 423. China Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Surgery K Unit (2025-2030)
  • Table 424. China Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Product K Unit (2025-2030)
  • Table 425. China Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by End User K Unit (2025-2030)
  • Table 426. Japan Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Target K Unit (2025-2030)
  • Table 427. Japan Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Surgery K Unit (2025-2030)
  • Table 428. Japan Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Product K Unit (2025-2030)
  • Table 429. Japan Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by End User K Unit (2025-2030)
  • Table 430. India Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Target K Unit (2025-2030)
  • Table 431. India Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Surgery K Unit (2025-2030)
  • Table 432. India Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Product K Unit (2025-2030)
  • Table 433. India Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by End User K Unit (2025-2030)
  • Table 434. South Korea Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Target K Unit (2025-2030)
  • Table 435. South Korea Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Surgery K Unit (2025-2030)
  • Table 436. South Korea Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Product K Unit (2025-2030)
  • Table 437. South Korea Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by End User K Unit (2025-2030)
  • Table 438. Taiwan Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Target K Unit (2025-2030)
  • Table 439. Taiwan Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Surgery K Unit (2025-2030)
  • Table 440. Taiwan Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Product K Unit (2025-2030)
  • Table 441. Taiwan Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by End User K Unit (2025-2030)
  • Table 442. Australia Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Target K Unit (2025-2030)
  • Table 443. Australia Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Surgery K Unit (2025-2030)
  • Table 444. Australia Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Product K Unit (2025-2030)
  • Table 445. Australia Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by End User K Unit (2025-2030)
  • Table 446. Rest of Asia-Pacific Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Target K Unit (2025-2030)
  • Table 447. Rest of Asia-Pacific Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Surgery K Unit (2025-2030)
  • Table 448. Rest of Asia-Pacific Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Product K Unit (2025-2030)
  • Table 449. Rest of Asia-Pacific Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by End User K Unit (2025-2030)
  • Table 450. Europe Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Country K Unit (2025-2030)
  • Table 451. Europe Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Target K Unit (2025-2030)
  • Table 452. Europe Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Surgery K Unit (2025-2030)
  • Table 453. Europe Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Product K Unit (2025-2030)
  • Table 454. Europe Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by End User K Unit (2025-2030)
  • Table 455. Germany Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Target K Unit (2025-2030)
  • Table 456. Germany Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Surgery K Unit (2025-2030)
  • Table 457. Germany Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Product K Unit (2025-2030)
  • Table 458. Germany Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by End User K Unit (2025-2030)
  • Table 459. France Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Target K Unit (2025-2030)
  • Table 460. France Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Surgery K Unit (2025-2030)
  • Table 461. France Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Product K Unit (2025-2030)
  • Table 462. France Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by End User K Unit (2025-2030)
  • Table 463. Italy Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Target K Unit (2025-2030)
  • Table 464. Italy Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Surgery K Unit (2025-2030)
  • Table 465. Italy Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Product K Unit (2025-2030)
  • Table 466. Italy Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by End User K Unit (2025-2030)
  • Table 467. United Kingdom Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Target K Unit (2025-2030)
  • Table 468. United Kingdom Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Surgery K Unit (2025-2030)
  • Table 469. United Kingdom Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Product K Unit (2025-2030)
  • Table 470. United Kingdom Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by End User K Unit (2025-2030)
  • Table 471. Netherlands Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Target K Unit (2025-2030)
  • Table 472. Netherlands Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Surgery K Unit (2025-2030)
  • Table 473. Netherlands Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Product K Unit (2025-2030)
  • Table 474. Netherlands Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by End User K Unit (2025-2030)
  • Table 475. Rest of Europe Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Target K Unit (2025-2030)
  • Table 476. Rest of Europe Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Surgery K Unit (2025-2030)
  • Table 477. Rest of Europe Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Product K Unit (2025-2030)
  • Table 478. Rest of Europe Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by End User K Unit (2025-2030)
  • Table 479. MEA Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Country K Unit (2025-2030)
  • Table 480. MEA Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Target K Unit (2025-2030)
  • Table 481. MEA Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Surgery K Unit (2025-2030)
  • Table 482. MEA Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Product K Unit (2025-2030)
  • Table 483. MEA Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by End User K Unit (2025-2030)
  • Table 484. Middle East Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Target K Unit (2025-2030)
  • Table 485. Middle East Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Surgery K Unit (2025-2030)
  • Table 486. Middle East Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Product K Unit (2025-2030)
  • Table 487. Middle East Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by End User K Unit (2025-2030)
  • Table 488. Africa Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Target K Unit (2025-2030)
  • Table 489. Africa Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Surgery K Unit (2025-2030)
  • Table 490. Africa Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Product K Unit (2025-2030)
  • Table 491. Africa Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by End User K Unit (2025-2030)
  • Table 492. North America Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Country K Unit (2025-2030)
  • Table 493. North America Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Target K Unit (2025-2030)
  • Table 494. North America Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Surgery K Unit (2025-2030)
  • Table 495. North America Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Product K Unit (2025-2030)
  • Table 496. North America Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by End User K Unit (2025-2030)
  • Table 497. United States Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Target K Unit (2025-2030)
  • Table 498. United States Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Surgery K Unit (2025-2030)
  • Table 499. United States Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Product K Unit (2025-2030)
  • Table 500. United States Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by End User K Unit (2025-2030)
  • Table 501. Canada Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Target K Unit (2025-2030)
  • Table 502. Canada Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Surgery K Unit (2025-2030)
  • Table 503. Canada Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Product K Unit (2025-2030)
  • Table 504. Canada Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by End User K Unit (2025-2030)
  • Table 505. Mexico Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Target K Unit (2025-2030)
  • Table 506. Mexico Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Surgery K Unit (2025-2030)
  • Table 507. Mexico Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Product K Unit (2025-2030)
  • Table 508. Mexico Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by End User K Unit (2025-2030)
  • Table 509. Research Programs/Design for This Report
  • Table 510. Key Data Information from Secondary Sources
  • Table 511. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices: by Target USD Million (2018-2023)
  • Figure 5. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices: by Surgery USD Million (2018-2023)
  • Figure 6. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices: by Product USD Million (2018-2023)
  • Figure 7. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices: by End User USD Million (2018-2023)
  • Figure 8. South America Minimally Invasive Glaucoma Surgery (MIGS) Devices Share (%), by Country
  • Figure 9. Asia Pacific Minimally Invasive Glaucoma Surgery (MIGS) Devices Share (%), by Country
  • Figure 10. Europe Minimally Invasive Glaucoma Surgery (MIGS) Devices Share (%), by Country
  • Figure 11. MEA Minimally Invasive Glaucoma Surgery (MIGS) Devices Share (%), by Country
  • Figure 12. North America Minimally Invasive Glaucoma Surgery (MIGS) Devices Share (%), by Country
  • Figure 13. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices: by Target K Unit (2018-2023)
  • Figure 14. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices: by Surgery K Unit (2018-2023)
  • Figure 15. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices: by Product K Unit (2018-2023)
  • Figure 16. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices: by End User K Unit (2018-2023)
  • Figure 17. South America Minimally Invasive Glaucoma Surgery (MIGS) Devices Share (%), by Country
  • Figure 18. Asia Pacific Minimally Invasive Glaucoma Surgery (MIGS) Devices Share (%), by Country
  • Figure 19. Europe Minimally Invasive Glaucoma Surgery (MIGS) Devices Share (%), by Country
  • Figure 20. MEA Minimally Invasive Glaucoma Surgery (MIGS) Devices Share (%), by Country
  • Figure 21. North America Minimally Invasive Glaucoma Surgery (MIGS) Devices Share (%), by Country
  • Figure 22. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices share by Players 2023 (%)
  • Figure 23. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices share by Players (Top 3) 2023(%)
  • Figure 24. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices share by Players (Top 5) 2023(%)
  • Figure 25. BCG Matrix for key Companies
  • Figure 26. Alcon Inc. (Switzerland) Revenue, Net Income and Gross profit
  • Figure 27. Alcon Inc. (Switzerland) Revenue: by Geography 2023
  • Figure 28. Ellex Medical Lasers Ltd. (Australia) Revenue, Net Income and Gross profit
  • Figure 29. Ellex Medical Lasers Ltd. (Australia) Revenue: by Geography 2023
  • Figure 30. Glaukos Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 31. Glaukos Corporation (United States) Revenue: by Geography 2023
  • Figure 32. Allergan Plc (United States) Revenue, Net Income and Gross profit
  • Figure 33. Allergan Plc (United States) Revenue: by Geography 2023
  • Figure 34. Santen Pharmaceutical Co., Ltd. (Japan) Revenue, Net Income and Gross profit
  • Figure 35. Santen Pharmaceutical Co., Ltd. (Japan) Revenue: by Geography 2023
  • Figure 36. Lumenis (United States) Revenue, Net Income and Gross profit
  • Figure 37. Lumenis (United States) Revenue: by Geography 2023
  • Figure 38. Ivantis, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 39. Ivantis, Inc. (United States) Revenue: by Geography 2023
  • Figure 40. SOLX, Inc (United States) Revenue, Net Income and Gross profit
  • Figure 41. SOLX, Inc (United States) Revenue: by Geography 2023
  • Figure 42. ISTAR Medical (Belgium) Revenue, Net Income and Gross profit
  • Figure 43. ISTAR Medical (Belgium) Revenue: by Geography 2023
  • Figure 44. InnFocus Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 45. InnFocus Inc. (United States) Revenue: by Geography 2023
  • Figure 46. Bausch & Lomb Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 47. Bausch & Lomb Inc. (United States) Revenue: by Geography 2023
  • Figure 48. Neomedix Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 49. Neomedix Corporation (United States) Revenue: by Geography 2023
  • Figure 50. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices: by Target USD Million (2025-2030)
  • Figure 51. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices: by Surgery USD Million (2025-2030)
  • Figure 52. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices: by Product USD Million (2025-2030)
  • Figure 53. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices: by End User USD Million (2025-2030)
  • Figure 54. South America Minimally Invasive Glaucoma Surgery (MIGS) Devices Share (%), by Country
  • Figure 55. Asia Pacific Minimally Invasive Glaucoma Surgery (MIGS) Devices Share (%), by Country
  • Figure 56. Europe Minimally Invasive Glaucoma Surgery (MIGS) Devices Share (%), by Country
  • Figure 57. MEA Minimally Invasive Glaucoma Surgery (MIGS) Devices Share (%), by Country
  • Figure 58. North America Minimally Invasive Glaucoma Surgery (MIGS) Devices Share (%), by Country
  • Figure 59. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices: by Target K Unit (2025-2030)
  • Figure 60. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices: by Surgery K Unit (2025-2030)
  • Figure 61. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices: by Product K Unit (2025-2030)
  • Figure 62. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices: by End User K Unit (2025-2030)
  • Figure 63. South America Minimally Invasive Glaucoma Surgery (MIGS) Devices Share (%), by Country
  • Figure 64. Asia Pacific Minimally Invasive Glaucoma Surgery (MIGS) Devices Share (%), by Country
  • Figure 65. Europe Minimally Invasive Glaucoma Surgery (MIGS) Devices Share (%), by Country
  • Figure 66. MEA Minimally Invasive Glaucoma Surgery (MIGS) Devices Share (%), by Country
  • Figure 67. North America Minimally Invasive Glaucoma Surgery (MIGS) Devices Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Alcon Inc. (Switzerland)
  • Ellex Medical Lasers Ltd. (Australia)
  • Glaukos Corporation (United States)
  • Allergan Plc (United States)
  • Santen Pharmaceutical Co., Ltd. (Japan)
  • Lumenis (United States)
  • Ivantis, Inc. (United States)
  • SOLX, Inc (United States)
  • iSTAR Medical (Belgium)
  • InnFocus Inc. (United States)
  • Bausch & Lomb Inc. (United States)
  • Neomedix Corporation (United States)
Additional players considered in the study are as follows:
Topcon Corporation (Japan) , New World Medical, Inc (United States) , Carl-Zeiss AG (Germany) , IOPtima (Israel) , Abbott Medical Optics, Inc. (United States)
Select User Access Type

Key Highlights of Report


Apr 2024 243 Pages 94 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Quantitative research analysis
Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Alcon Inc. (Switzerland), Ellex Medical Lasers Ltd. (Australia), Glaukos Corporation (United States), Allergan Plc (United States), Santen Pharmaceutical Co., Ltd. (Japan), Lumenis (United States), Ivantis, Inc. (United States), SOLX, Inc (United States), iSTAR Medical (Belgium), InnFocus Inc. (United States), Bausch & Lomb Inc. (United States) and Neomedix Corporation (United States) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Increase in Focus of Key Players in the Development of MIGS Stents " is seen as one of major influencing trends for Minimally Invasive Glaucoma Surgery (MIGS) Devices Market during projected period 2023-2030.
The Minimally Invasive Glaucoma Surgery (MIGS) Devices market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Report?

Have a Query? Click Here

Other Related Reports

Optical Colposcopy Comprehensive Study by Application (Cervical Cancer Diagnostic, Physical Examination, Other), End User (Hospitals, Gynecology Clinics, Diagnostic Center, Research & Academics) Play...
$ 3500
Spinal Fusion Devices Comprehensive Study by Type (Cervical Devices, Thoracolumbar Devices, Interbody Devices, Biologics), Application (Degenerative Disc Disease, Complex Deformity, Traumas & Fractur...
$ 3750
Medical Surgical Lasers Comprehensive Study by Type (Diode Lasers, Solid-State Lasers, Gas Lasers, Dye Lasers), Application (Ophthalmology, Urology, Gynaecology, Dermatology, Dental, Cardiology, Onco...
$ 3450
Centesis Catheters Comprehensive Study by Type (Small-bore CentesisCatheters, Large-bore Centesis Catheters), Application (Short-term Drainage Procedures, Percutaneous Fluid Aspirations), Distributio...
$ 3750
Enteral Feeding Device Comprehensive Study by Type (Enteral Feeding Pumps, Enteral Feeding Tubes, Administration Sets, Enteral Syringes, Other Consumables (Extension sets, adaptors, tapes)), Applicat...
$ 3750
Rapid Infuser Comprehensive Study by Type (Trolley Mounted Devices, Handheld Devices), Application (Hospitals, Ambulatory surgery centers (ASCs), Specialty Clinics), Usability (Single-Use, Reusable) ...
$ 3500